CSI Market
Sign In | Register

Bioxcel Therapeutics Inc (BTAI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BTAI Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Bioxcel Therapeutics Inc.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent12.84
Cash & Short-term Investments12.00
Accounts receivable0.08
Inventories0.48
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.07
Total Current Assets28.70
Equipment/Property/Plant Net1.98
Long-term investments13.80
Restricted Cash Current-
Operating Lease Right Of Use Asset-
Total Assets28.80
Liabilities
Accounts Payable, Current AC18.78
Accrued Liabilities, Current AC3.92
Long-term Debt, Current Maturities LO104.45
Other Liabilities, Current9.95
Taxes Payable0.04
Total Current Liabilities137.15
Long-term debt104.45
Total Long-term Debt104.45
Derivative Liability, Noncurrent DE7.11
Total Liabilities144.26
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock632.01
Retained Earnings / Accumulated Deficit-747.50
Other Equity0.00
Common Stockholder's Equity-115.46
Total Stockholder's Equity-115.46
Liabilities & Stockholder's Equity28.80
4 historic quarters locked

Sign in to unlock the full Bioxcel Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Bioxcel Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-095965

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.